|
2025
|
G/S
|
Educational services, namely, providing presentations in the field of oncology products and disea... |
|
|
G/S
|
Pharmaceutical preparations, applied subcutaneously, for use in oncology |
|
|
G/S
|
Pharmaceutical preparations for use in neurological disorders including Alzheimer's |
|
|
G/S
|
Pharmaceutical preparations for use in oncology |
|
|
G/S
|
Pharmaceutical preparations for use in the treatment of neurological conditions including Alzheim... |
|
|
G/S
|
Pharmaceutical preparations for use in neuroscience |
|
|
G/S
|
Ophthalmological apparatus and instruments, namely, implantable ocular drug delivery devices |
|
|
Invention
|
Diagnostic and therapeutic methods for the treatment of rheumatoid arthritis (ra).
The present i... |
|
|
Invention
|
Probabilistic identification of features for machine learning enabled cellular phenotyping.
A me... |
|
|
Invention
|
Deep learning for non-compartmental analysis.
A method may include training a machine learning m... |
|
|
Invention
|
Methods and compositions comprising purified recombinant polypeptides.
Purified recombinant poly... |
|
|
Invention
|
Simultaneous imaging of nucleic acid and protein in a sample.
The present disclosure relates to ... |
|
|
Invention
|
Biomolecule fitness inference using machine learning for drug discovery with directed evolution. ... |
|
|
Invention
|
T cell quantitative systems pharmacology model.
A method may include determining, by at least on... |
|
|
Invention
|
Molecule design with multi-objective optimization of partially ordered, mixed-variable molecular ... |
|
|
Invention
|
Optimizing polypeptide sialic acid content.
We provide a method of optimizing sialic acid conten... |
|
|
Invention
|
Methods for treatment of cd20-positive proliferative disorder with mosunetuzumab and polatuzumab ... |
|
|
Invention
|
Machine learning enabled prediction of molecular structures and properties.
A method may include... |
|
|
Invention
|
Techniques for determining dopaminergic neural cell loss using machine learning.
Described herei... |
|
|
Invention
|
Spacetime attention for clinical outcome prediction.
A disease prognosis model to may be trained... |
|
|
Invention
|
Cross-modality pixel alignment and cell-to-cell registration across various imaging modalities.
... |
|
|
Invention
|
Deduplication of sample images.
A method includes identifying, based at least on an identificati... |
|
|
Invention
|
Apparatus for subretinal administration of therapeutic agent via dual-curved needle.
An apparatu... |
|
|
G/S
|
Software products for healthcare, monitoring, screening, assessment, diagnosis, and intervention,... |
|
|
Invention
|
Therapeutic and diagnostic methods for bladder cancer.
The invention provides methods and compos... |
|
|
Invention
|
Quantifying amyloid-related imaging abnormalities (aria) in alzheimer's patients.
Methods for qu... |
|
|
Invention
|
Segmenting and detecting amyloid-related imaging abnormalities (aria) in alzheimer's patients.
M... |
|
|
Invention
|
Data-independent acquisition (dia) for mass spectrometric analysis of mhc peptides. e.g.e.g., a p... |
|
|
Invention
|
Processes for making 1h-pyrazolo [3, 4-b] pyrazine compounds. Hbb]pyrazine compound of formula (I... |
|
|
Invention
|
Rna ligase variants. The present invention provides RNA ligase variants and its use in ligation r... |
|
|
Invention
|
Anti-c-c motif chemokine receptor 8 (ccr8) antibodies and methods of use.
The present disclosure... |
|
|
Invention
|
Methods and materials for measuring complement activation. e.g.e.g., in clinical samples, such as... |
|
|
Invention
|
Guab inhibitor compounds and uses thereof. e.g.e.g.e.g., tuberculosis, leprosy, nontuberculous my... |
|
|
Invention
|
Method of treating hemophilia a. The present invention relates to methods of increasing hemoglobi... |
|
|
Invention
|
Methods of treating urothelial carcinoma with a pd-1 axis binding antagonist and an rna vaccine. ... |
|
|
Invention
|
Targeted protein degradation using bacterial e3 ligase. The present disclosure relates to a novel... |
|
|
Invention
|
Combinations of il15/il15r alpha heterodimeric fc-fusion proteins and fcrh5xcd3 bispecific antibo... |
|
2024
|
Invention
|
Anti-polyubiquitin antibodies.
The invention provides anti-polyubiquitin antibodies and methods ... |
|
|
Invention
|
Composition and methods for adeno-associated virus producing stable human embryonic kidney-293 ce... |
|
|
Invention
|
Optical imaging of nucleic acids. The present disclosure relates to improved methods for imaging ... |
|
|
Invention
|
Reducing alpha-gal. The disclosure relates to methods of producing a glycoprotein with reduced a-... |
|
|
G/S
|
Pharmaceutical preparations for use in immunology |
|
|
G/S
|
Pharmaceutical preparations for use in oncology, neurology and immunology |
|
|
Invention
|
Preparation of tissue samples for imaging. The present disclosure involves preparing a cryostat t... |
|
|
Invention
|
Machine learning enabled analysis of medical imaging data for assessment of disease progression a... |
|
|
Invention
|
System and method for imaging of tissue samples. The present disclosure involves generating a vie... |
|
|
Invention
|
Methods of structure determination using antibodies. Herein is provided a method of determining a... |
|
|
Invention
|
Steered molecular dynamics based native pose and affinity prediction for protein-ligand complexes... |
|
|
G/S
|
Pharmaceutical preparations for use in immunology; Pharmaceutical preparations for the treatment ... |
|
|
G/S
|
Pharmaceutical preparations for the treatment of metabolic diseases and disorders, Pharmaceutical... |
|
|
Invention
|
Disulfide isoform modulation. This invention relates to a method for modulation of disulfide stru... |
|
|
G/S
|
Pharmaceutical preparations for the prevention and treatment of neurological diseases |
|
|
G/S
|
Pharmaceutical preparations for use in the treatment of neurological conditions including Alzheimer |
|
|
G/S
|
Pharmaceutical preparations for use in the treatment of neurological conditions including Alzheimer. |
|
|
Invention
|
Therapeutic and diagnostic methods for cancer.
The present invention provides therapeutic, diagn... |
|
|
Invention
|
Compositions and methods of use.
The invention relates to compositions (e.g., pharmaceutical com... |
|
|
Invention
|
Prevention of disulfide bond reduction during recombinant production of polypeptides.
The invent... |
|
|
Invention
|
Lactams as cbl-b inhibitors.
Various lactam compound that binds Cbl-B, many of which are selecti... |
|
|
G/S
|
Pharmaceutical preparations for use in ophthalmology |
|
|
G/S
|
Pharmaceutical preparations for use in ophthalmology. |
|
|
G/S
|
Electronic data collection for business purposes in the medical field Downloadable and recorded c... |
|
|
G/S
|
Education, namely providing training in the field of oncology Medical services, namely, providing... |
|
|
G/S
|
Ophthalmological apparatus and instruments for ophthalmological surgery Education, namely providi... |
|
|
Invention
|
Benzoxazepin oxazolidinone compounds and methods of use.
Described herein are benzoxazepin oxazo... |
|
|
Invention
|
Peak deconvolution for chromatographic time-series composite signals.
The present disclosure is ... |
|
|
G/S
|
Pharmaceutical preparations for use in oncology and hematology |
|
|
Invention
|
Highly concentrated pharmaceutical formulations.
The present invention relates to a highly conce... |
|
|
G/S
|
Pharmaceutical preparations for the prevention and treatment of neurological and neurodegenerativ... |
|
|
G/S
|
Pharmaceutical ophthalmic preparations |
|
2023
|
Invention
|
Determining a patient’s response to a treatment in multiple myeloma.
The present disclosure rela... |
|
|
Invention
|
Machine learning enabled restoration of low resolution images.
A method may include training a m... |
|
2017
|
Invention
|
Methods of administering anti-fibrotic therapy. The present disclosure relates to Compound I (See... |
